high risk neuroblastoma
Showing 1 - 5 of 5
High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,
Recruiting
- High Risk Neuroblastoma
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +10 more
Jan 19, 2023
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
High Risk Neuroblastoma Trial in United States (biological, other, drug)
Completed
- High Risk Neuroblastoma
- Aldesleukin
- +4 more
-
Loma Linda, California
- +31 more
Jul 30, 2021
High Risk Neuroblastoma Trial (Cyclophosphamide, Carboplatin, Etoposide)
Unknown status
- High Risk Neuroblastoma
- Cyclophosphamide
- +5 more
- (no location specified)
Sep 17, 2018